Scientific Director, Health Systems at Acadia Pharmaceuticals

Seattle, Washington, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, Pharmaceutical, HealthcareIndustries

Requirements

Clinical or scientific degree required (e.g., MD, PharmD, PhD, MS, MPH, etc.)
5+ years’ experience in IDN and payer space and the ability to develop peer-to-peer relationships with key decision makers (may be gained through working on the customer side or in an industry role working with these customers)
Thorough knowledge of payer and IDN organizational practices
Thorough knowledge of clinical medicine, the managed market environment, pharmacoeconomics, disease management, real-world evidence generation and medical research
Business and market knowledge, including quality management, formulary management and pathway development/management
Excellent interpersonal communication skills, strong presentation skills
Ability to work with cross functional field account teams
Strong personal integrity, collaborative mindset, and strong customer focus
Thorough understanding of the FDA, OIG, HIPAA and other ethical guidelines, laws and regulations relevant to the pharmaceutical industry
Ability to organize, prioritize, and work effectively in a constantly changing environment, and demonstrated project leadership abilities
Preferred: Formal training in health economics

Responsibilities

Develops ongoing professional relationships with key decision makers in organized health systems to ensure access to medical and scientific information on Madrigal’s products, development programs and related disease area(s)
Partners with the Market Access and Key Account Director (KAD) teams to develop strategic account plans; execute medical activities in alignment with agreed plan
Effectively communicates and coordinates with regional MSLs and CPLs regarding medical and scientific support needs in key affiliated regional health systems – IDNs, GI practices and regional payers
Serves as a resource for the Health Systems Executive Director and other members of market access and KAD organizations on relevant strategic planning
Provides support for HEOR activities led by HQ HEOR within regional accounts of responsibility
Serves as a technical resource on questions raised by market access and KAD team members
Attend and support scientific and medical meetings; prepares planned post-meeting deliverables

Skills

Key technologies and capabilities for this role

HEORReal-World EvidenceMedical AffairsStakeholder EngagementScientific CommunicationPayer RelationsStrategic PlanningDisease State ExpertiseClinical Science

Questions & Answers

Common questions about this position

What is the location requirement for this role?

The position is open to candidates in Washington, Oregon, Idaho, Wyoming, Utah, Colorado, Kansas, Nebraska, North & South Dakota.

What salary or compensation does this position offer?

This information is not specified in the job description.

What are the required qualifications for this role?

A clinical or scientific degree is required, such as MD, PharmD, PhD, MS, or MPH, along with 5+ years’ experience in IDN and payer space and the ability to develop peer-to-peer relationships with key decision makers.

What does the team structure look like for this position?

The role works closely with account executives, key account managers, regional MSLs, CPLs, the Health Systems Executive Director, market access and KAD teams, and serves as a resource for Global Medical Affairs management.

What makes a strong candidate for this Scientific Director role?

Strong candidates will have a clinical or scientific degree and at least 5+ years of experience in the IDN and payer space with proven ability to build peer-to-peer relationships with key decision makers.

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free